Abstract Study Objectives The most commonly prescribed antibiotics for patients with
hospital‐acquired bacterial pneumonia (HABP) and ventilator‐associated bacterial …

Purpose This case-case-control study aims to identify clinical predictors for pneumonia due
to Pseudomonas aeruginosa (PA) which is (1) susceptible to all routinely tested …

Background The impact of antibiotic resistance on the outcome of infections due to Gram-
negative bacilli, especially Pseudomonas, remains highly controversial. Study objective …

Objectives Resistance to all β-lactams is emerging among Pseudomonas aeruginosa (PA)
clinical isolates. Aztreonam and cefepime act synergistically in vitro against AmpC …

Pseudomonas aeruginosa (PA), a nonlactose fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …

Background Challenges due to multidrug resistant (MDR) Gram-negative bacterial
pathogens such as P. aeruginosa (PSA) are increasing globally. Suboptimal antimicrobial …

Background Carbapenem-nonsusceptible and multidrug-resistant (MDR) P. aeruginosa,
which are more common in patients with lower respiratory tract infections (LRTIs) and in …

Study Objective Minimizing the duration of broad‐spectrum antimicrobial exposure in the
critically ill is a commonly used strategy aimed at preventing resistance. Our objective was to …

Pseudomonas aeruginosa, a frequent pathogen in the intensive care unit (ICU), has the
propensity to develop antibiotic resistance. In particular, carbapenem-nonsusceptible (NS) …

Abstract Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) isolates can
frequently retain susceptibility to traditional antipseudomonal β-lactams including cefepime …